Spondylo-arthritis Screening Tool Among Patient Suffering From Inflammatory Bowel Disease
Launched by UNIVERSITY HOSPITAL, GRENOBLE · May 21, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The QUESAM study is a clinical trial aimed at helping doctors identify spondylo-arthritis in patients who have inflammatory bowel disease, such as Crohn's disease or ulcerative colitis. Researchers will translate two specific questionnaires from English to French, and then check to ensure that the translations are accurate. These questionnaires are tools that help determine whether someone might benefit from seeing a specialist for joint-related issues. Participants will be asked to fill out these questionnaires twice: once during a consultation and again after one month.
To be eligible for this study, participants need to have a diagnosis of inflammatory bowel disease confirmed by a gastroenterologist. There are no major exclusions, but individuals who have trouble understanding or reading French, those without social security coverage, or those who do not wish to participate voluntarily will not be included. Since the study is not yet recruiting, this is an opportunity for patients to contribute to important research that may improve care for those with related conditions.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient with an inflammatory bowel disease according to gastroenterologist
- Exclusion Criteria:
- • No exclusion criteria
- • Difficulty for understanding or reading french
- • Persons covered by articles L1121-5 to L1121-8 of the French Public Health Code
- • Patients with no social security coverage.
- • Patients refusing to participate voluntarily.
About University Hospital, Grenoble
The University Hospital of Grenoble is a leading academic medical center dedicated to advancing healthcare through innovative clinical research and comprehensive patient care. As a prominent sponsor of clinical trials, the hospital leverages its expertise in various medical disciplines to facilitate cutting-edge studies that aim to improve treatment outcomes and enhance patient safety. With a strong commitment to collaboration, the University Hospital of Grenoble engages in partnerships with academic institutions, industry leaders, and regulatory bodies to drive scientific discovery and translate research findings into clinical practice. Its state-of-the-art facilities and multidisciplinary teams ensure rigorous adherence to ethical standards and regulatory guidelines, fostering an environment where groundbreaking research can thrive.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Grenoble, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported